Cavallari, Larisa Humma
- University of Florida · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,670
- Rising Star
- Program Leader
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,670
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Cavallari, Larisa Humma as a PI. Multi-PI records show the full award amount for context.
- 3U01HG007269-09S2U01Contact PIIGNITE Cost Extension - Admin SupplementUniversity of Florida · Pharmacology (NIH department code)$1.4Maward amount
- 5R01HL149752-04R01Contact PIPrecision antiplatelet therapy after percutaneous coronary interventionUniversity of Florida · Pharmacology (NIH department code)$682.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Cavallari, Larisa Humma as a PI.
FY2023 award administered by University of Florida (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardUniversity of Florida
- 2014$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #7114
- 2015R01 Grant Holder
- 2016$2M Cumulative Funding
- 2016Program/Center Grant Leader
- 2022$5M Cumulative Funding
- 2022Entered Top 25% NationallyRanked #2024